MNTL

MNTL
About Tema Neuroscience And Mental Health ETF
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
About Tema Neuroscience And Mental Health ETF
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
VRTX | Vertex Pharmaceuticals Incorporated | 10.33% | 2.30K | $1.06M |
REGN | Regeneron Pharmaceuticals, Inc. | 8.09% | 1.49K | $831.60K |
ALNY | Alnylam Pharmaceuticals, Inc. | 7.74% | 1.98K | $796.37K |
ARGX | argenx SE | 5.83% | 890 | $599.68K |
NBIX | Neurocrine Biosciences, Inc. | 4.89% | 3.90K | $503.26K |
TEVA | Teva Pharmaceutical Industries Limited | 4.32% | 28.86K | $443.88K |
LLY | Eli Lilly and Company | 4.05% | 547 | $416.99K |
CRNX | Crinetics Pharmaceuticals, Inc. | 3.54% | 13.07K | $363.76K |
IONS | Ionis Pharmaceuticals, Inc. | 3.48% | 8.32K | $357.92K |
SYK | Stryker Corporation | 3.22% | 877 | $331.32K |
BIIB | Biogen Inc. | 3.21% | 2.50K | $330.01K |
MDT | Medtronic plc | 2.59% | 2.98K | $265.88K |
ACAD | ACADIA Pharmaceuticals Inc. | 2.42% | 10.60K | $249.32K |
AXSM | Axsome Therapeutics, Inc. | 2.33% | 2.33K | $239.73K |
CPRX | Catalyst Pharmaceuticals, Inc. | 2.33% | 11.35K | $239.75K |
DNLI | Denali Therapeutics Inc. | 1.98% | 15.17K | $203.94K |
RNA | Avidity Biosciences, Inc. | 1.88% | 5.39K | $193.68K |
JAZZ | Jazz Pharmaceuticals plc | 1.88% | 1.67K | $193.15K |
XENE | Xenon Pharmaceuticals Inc. | 1.81% | 6.11K | $186.38K |
DXCM | DexCom, Inc. | 1.72% | 2.23K | $176.87K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
ARGX
argenx SE
NBIX
Neurocrine Biosciences, Inc.
TEVA
Teva Pharmaceutical Industries Limited
LLY
Eli Lilly and Company
CRNX
Crinetics Pharmaceuticals, Inc.
IONS
Ionis Pharmaceuticals, Inc.
SYK
Stryker Corporation
BIIB
Biogen Inc.
MDT
Medtronic plc
ACAD
ACADIA Pharmaceuticals Inc.
AXSM
Axsome Therapeutics, Inc.
CPRX
Catalyst Pharmaceuticals, Inc.
DNLI
Denali Therapeutics Inc.
RNA
Avidity Biosciences, Inc.
JAZZ
Jazz Pharmaceuticals plc
XENE
Xenon Pharmaceuticals Inc.
DXCM
DexCom, Inc.
